While developing its nanomedicine pipeline, CARLINA Technologies focuses its activities on providing high quality R&D formulation development services to the pharmaceutical, veterinary and biotechnology industries utilizing both its proprietary controlled drug delivery platforms as well as its experience using many other systems including liposomes, micelles, microspheres, hydrogels, organogels, etc.
For each project, CARLINA Technologies takes industrial, economic and commercial requirements into consideration according to specific products and corresponding therapeutic applications. CARLINA’s expertise in project management allows rigourous development phase evaluation and control.
The creativity of CARLINA Technologies results from the complementarity and skills of its team members, acquired experience from diversified and complex projects as well as advanced competitive intelligence knowledge. This is the basis for bringing unique solutions as well as original innovation and valorization axes proposed to our clients and partners.
Each study benefits from combined high level scientific input from international well recognized experts in the field of controlled drug delivery and high quality specific analytical equipments and methodologies (high performance liquid chromatography, dynamic light scattering, electron microscopy, electrophoretic mobility, etc.)
Following early laboratory scale production feasibility studies, CARLINA Technologies’ manufacturing processes allow rapid determination and validation of transposition conditions for successful product manufacturing at industrial scales.